The DOI matches its Crossref record; 49 of the 49 references it cites were found in a registry or an index.
Doxorubicin‐Loaded Polymeric Micelle Overcomes Multidrug Resistance of Cancer by Double‐Targeting Folate Receptor and Early Endosomal pH
Open accessAbstract
An optimized, pH‐sensitive mixed‐micelle system conjugated with folic acid is prepared in order to challenge multidrug resistance (MDR) in cancers. The micelles are composed of poly(histidine (His)‐co‐phenylalanine (Phe))‐b‐poly(ethylene glycol) (PEG) and poly(L‐lactic acid) (PLLA)‐b‐PEG‐folate. Core‐forming, pH‐sensitive hydrophobic blocks of poly(His‐co‐Phe) of varying composition are synthesized. The pH sensitivity of the micelles is controlled by the copolymer composition and is fine tuned to early endosomal pH by blending PLLA(3K)‐b‐PEG(2K)‐folate in the presence of a basic anticancer drug, doxorubicin (DOX). In vitro tests are conducted against both wild‐type (A2780) and DOX‐resistant ovarian carcinoma cell lines. A mixed‐micelle system composed of poly(His‐co‐Phe (16 mole%))‐b‐PEG (80 wt%) and PLLA‐b‐PEG‐folate (20 wt%) is selected to target early endosomal pH. DOX‐loaded micelles effectively kill both wild‐type sensitive (A2780) and DOX‐resistant ovarian MDR cancer‐cell lines (A2780/DOX R) through an instantaneous high dose of DOX in the cytosol, which results from active internalization, accelerated DOX release triggered by endosomal pH, and an endosomal membrance disruption.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Solid lipid nanoparticles (SLN) for controlled drug delivery â a review of the state of the art
Müller, R. (2000) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/s0939-6411(00)00087-4 · Cited by 3,759
Gabizón, A., Catane, R., Uziely, B., Kaufman, B., Safra, T., Cohen, R., Martin, F., Huang, A., & Barenholz, Y. (1994) · PubMed · Cited by 1,382
Amplification of P-glycoprotein genes in multidrug-resistant mammalian cell lines
Riordan, J. R., Deuchars, K., Kartner, N., Alon, N., Trent, J., & Ling, V. (1985) · Nature · doi:10.1038/316817a0 · Cited by 826
Pluronic® block copolymers for overcoming drug resistance in cancer
Kabanov, A. V., Batrakova, E. V., & Alakhov, V. Y. (2002) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(02)00047-9 · Cited by 636
Polymeric micelle for tumor pH and folate-mediated targeting
Lee, E. (2003) · Journal of Controlled Release · doi:10.1016/s0168-3659(03)00239-6 · Cited by 618
Self-citationMechanism of multidrug resistance
Bradley, G., Juranka, P. F., & Ling, V. (1988) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/0304-419x(88)90006-6 · Cited by 617
P-glycoprotein and multidrug resistance
Gottesman, M. M., Pastan, I., & Ambudkar, S. V. (1996) · Current Opinion in Genetics & Development · doi:10.1016/s0959-437x(96)80091-8 · Cited by 560
The role of Bcl-2 family members in tumorigenesis
Kirkin, V., Joos, S., & Zörnig, M. (2004) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2003.08.009 · Cited by 548
Polymer-based gene delivery with low cytotoxicity by a unique balance of side-chain termini
Putnam, D. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.031577698 · Cited by 510
P‐glycoprotein: multidrug‐resistance and a superfamily of membrane‐associated transport proteins
Juranka, P. F., Zastawny, R. L., & Ling, V. (1989) · The FASEB Journal · doi:10.1096/fasebj.3.14.2574119 · Cited by 503
Panyam, J., & Labhasetwar, V. (2003) · Pharmaceutical Research · doi:10.1023/a:1022219003551 · Cited by 466
Folate-binding protein is a marker for ovarian cancer.
Campbell, I., Jones, T. A., Foulkes, W. D., & Trowsdale, J. (1991) · PubMed · Cited by 457
Chemotherapy of glioblastoma in rats using doxorubicin‐loaded nanoparticles
Steiniger, S. C. J., Kreuter, J., Khalansky, A. S., Skidan, I. N., Bobruskin, A. I., Smirnova, Z. S., Severin, S. E., Uhl, R., Kock, M., Geiger, K. D., et al. (2004) · International Journal of Cancer · doi:10.1002/ijc.20048 · Cited by 434
Benns, J. M., Choi, J.-S., Mahato, R. I., Park, J.-S., & Kim, S. W. (2000) · Bioconjugate Chemistry · doi:10.1021/bc0000177 · Cited by 381
Cell biological mechanisms of multidrug resistance in tumors.
Simon, S. M., & Schindler, M. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.9.3497 · Cited by 369
Multidrug resistance mediated by the ATP-binding cassette transporter protein MRP
Cole, S. P. C., & Deeley, R. G. (1998) · BioEssays · doi:10.1002/(sici)1521-1878(199811)20:11<931::aid-bies8>3.0.co;2-j · Cited by 342
Hager, A., Debus, G., Edel, H. G., Stransky, H., & Serrano, R. (1991) · Planta · doi:10.1007/bf00202963 · Cited by 337
Krishnamachary, N., & M S Center (1993) · PubMed · Cited by 296
Emilienne Soma, C., Dubernet, C., Bentolila, D., Benita, S., & Couvreur, P. (2000) · Biomaterials · doi:10.1016/s0142-9612(99)00125-8 · Cited by 281
Cytotoxicity of Solid Lipid Nanoparticles as a Function of the Lipid Matrix and the Surfactant
Müller, R. H., Rühl, D., Runge, S., Schulze-Forster, K., & Mehnert, W. (1997) · Pharmaceutical Research · doi:10.1023/a:1012043315093 · Cited by 265
Deffie, A. M., Batra, J. K., & Goldenberg, G. J. (1989) · PubMed · Cited by 261
Duncan, R. (1999) · Pharmaceutical Science & Technology Today · doi:10.1016/s1461-5347(99)00211-4 · Cited by 192
Tumor acidity, ion trapping and chemotherapeutics
Raghunand, N., Mahoney, B. P., & Gillies, R. J. (2003) · Biochemical Pharmacology · doi:10.1016/s0006-2952(03)00468-4 · Cited by 182
Modulation of multidrug resistance: at the threshold.
Sikic, B. I. (1993) · Journal of Clinical Oncology · doi:10.1200/jco.1993.11.9.1629 · Cited by 182
Liposome-based approaches to overcome anticancer drug resistance
Mamot, C., Drummond, D. C., Hong, K., Kirpotin, D. B., & Park, J. W. (2003) · Drug Resistance Updates · doi:10.1016/s1368-7646(03)00082-7 · Cited by 170
Yin, H., Lee, E. S., Kim, D., Lee, K. H., Oh, K. T., & Bae, Y. H. (2008) · Journal of Controlled Release · doi:10.1016/j.jconrel.2007.11.014 · Cited by 168
Self-citationde Verdière, A., Dubernet, C., Némati, F., Soma, E., Appel, M., Ferté, J., Bernard, S., Puisieux, F., & Couvreur, P. (1997) · British Journal of Cancer · doi:10.1038/bjc.1997.362 · Cited by 168
Clinical Studies with Modulators of Multidrug Resistance
Fisher, G. A., & Sikic, B. I. (1995) · Hematology/Oncology Clinics of North America · doi:10.1016/s0889-8588(18)30099-6 · Cited by 163
The role of p53 in treatment responses of lung cancer
Viktorsson, K., De Petris, L., & Lewensohn, R. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.03.192 · Cited by 161
Glutathione-related mechanisms in cellular resistance to anticancer drugs.
Zhang, K., Mack, P., & Wong, K. P. (1998) · International Journal of Oncology · doi:10.3892/ijo.12.4.871 · Cited by 159
Slovak, M. L., Ho, J. P., Bhardwaj, G., Kurz, E. U., Deeley, R. G., & Cole, S. P. C. (1993) · PubMed · Cited by 151
Transcriptional Activation of the MDR1 Gene by UV Irradiation
Hu, Z., Jin, S. V., & Scotto, K. W. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.4.2979 · Cited by 146
Gao, Z., Lee, D. H., Kim, D., & Bae, Y. H. (2005) · Journal of drug targeting · doi:10.1080/10611860500376741 · Cited by 135
Self-citationBy-passing of P-glycoprotein Using Immunoliposomes
Huwyler, J., Cerletti, A., Fricker, G., Eberlé, A. N., & Drewe, J. (2002) · Journal of drug targeting · doi:10.1080/10611860290007559 · Cited by 125
Structure and Function of P-Glycoprotein in Normal Liver and Small Intestine
Gatmaitan, Z., & Arias, I. M. (1993) · Advances in pharmacology · doi:10.1016/s1054-3589(08)60934-5 · Cited by 106
Modulation of doxorubicin resistance in multidrug‐resistant cells by liposomes
Thierry, A. R., Vigé, D., Coughlin, S. S., Belli, J. A., Dritschilo, A., & Rahman, A. (1993) · The FASEB Journal · doi:10.1096/fasebj.7.6.8097173 · Cited by 105
The (patho)physiological functions of the MRP family
Renes, J., de Vries, E. G. E., Jansen, P. L. M., & Müller, M. M. (2000) · Drug Resistance Updates · doi:10.1054/drup.2000.0156 · Cited by 100
Resistance to cytotoxic and anti-angiogenic anticancer agents: similarities and differences
Broxterman, H. J., Lankelma, J., & Hoekman, K. (2003) · Drug Resistance Updates · doi:10.1016/s1368-7646(03)00026-8 · Cited by 91
Han, S. K., Na, K., & Bae, Y. H. (2003) · Colloids and Surfaces A Physicochemical and Engineering Aspects · doi:10.1016/s0927-7757(02)00389-8 · Cited by 91
Self-citationKeller, R. P., Altermatt, H. J., Donatsch, P., et al. (1992) · International Journal of Cancer · doi:10.1002/ijc.2910510316 · Cited by 80
Mohajer, G., Lee, E. S., & Bae, Y. H. (2007) · Pharmaceutical Research · doi:10.1007/s11095-007-9277-5 · Cited by 73
Self-citationNémati, F. (1996) · International Journal of Pharmaceutics · doi:10.1016/0378-5173(96)04559-0 · Cited by 67
Storm, G., ten Kate, M. T., Working, P. K., & Bakker‐Woudenberg, I. A. J. M. (1998) · PubMed · Cited by 64
Sutton, D. M., Wang, S., Nasongkla, N., Gao, J., & Dormidontova, E. E. (2007) · Experimental Biology and Medicine · doi:10.3181/0702-rm-31 · Cited by 62
Evidence for nonspecific adsorption of targeted retrovirus vector particles to cells
Pizzato, M., Blair, E., Fling, M., Kopf, J., Tomassetti, A., Weiss, R. A., & Takeuchi, Y. (2001) · Gene Therapy · doi:10.1038/sj.gt.3301494 · Cited by 61
Liu, Z., Wu, X. Y., & Bendayan, R. (1999) · Journal of Pharmaceutical Sciences · doi:10.1021/js9803353 · Cited by 59
Prompruk, K., Govender, T., Zhang, S., Xiong, C. D., & Stolnik, S. (2005) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2005.02.025 · Cited by 47
Tomonaga, M., Oka, M., 楢崎, 史., Fukuda, M., Nakano, R., Takatani, H., Ikeda, K., Terashi, K., Matsuo, I., Soda, H., et al. (1996) · Japanese Journal of Cancer Research · doi:10.1111/j.1349-7006.1996.tb03142.x · Cited by 41
Cellular Resistance to Cancer Chemotherapy
Skovsgaard, T., Nielsen, D., Maare, C., & Wassermann, K. (1994) · International review of cytology · doi:10.1016/s0074-7696(08)62253-6 · Cited by 39
Cited by
Stimuli-responsive nanocarriers for drug delivery
Mura, S., Nicolas, J., & Couvreur, P. (2013) · Nature Materials · doi:10.1038/nmat3776 · Cited by 6,289
Danhier, F., Feron, O., & Préat, V. (2010) · Journal of Controlled Release · doi:10.1016/j.jconrel.2010.08.027 · Cited by 2,800
Targeted polymeric therapeutic nanoparticles: design, development and clinical translation
Kamaly, N., Xiao, Z., Valencia, P. M., Radovic-Moreno, A. F., & Farokhzad, O. C. (2012) · Chemical Society Reviews · doi:10.1039/c2cs15344k · Cited by 1,730
Multifunctional, stimuli-sensitive nanoparticulate systems for drug delivery
Torchilin, V. P. (2014) · Nature Reviews Drug Discovery · doi:10.1038/nrd4333 · Cited by 1,663
Biodegradable synthetic polymers: Preparation, functionalization and biomedical application
Tian, H., Tang, Z., Zhuang, X., Chen, X., & Jing, X. (2012) · Progress in Polymer Science · doi:10.1016/j.progpolymsci.2011.06.004 · Cited by 1,293
Metadata
- Authors
- Kim, D., Lee, E. S., Oh, K. T., Gao, Z. G., & Bae, Y. H.
- Venue
- Small
- Publisher
- Wiley
- Published
- 2008-11
- Volume
- 4
- Issue
- 11
- Pages
- 2043-2050
- ISSN
- 1613-6810 (ISSN-L)
- 1613-6829
- OpenAlex
- W2118411153
- Cited by
- 313
- References
- 49
- FWCI
- 7.84
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.